CEACAM5 and metastatic malignant neoplasm in the lymph nodes: Patients’ gender, lymph node metastasis, pleural membranes, pleural congestion, pleural adhesion, treatment plan, and serum CEA level were used to predict 2-year OS in patients with pleural metastases with 19-del and 21L858R mutations.